New NIDDK Funding Opportunity: Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

Here is the announcement from NIDDK:

"Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)

(RFA-DK-20-021)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): December 16, 2020

Purpose:

The purpose of this Funding Opportunity Announcement (FOA) is to support basic and clinical mechanistic research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes in organs, tissues, and biological systems of specific interest to NIDDK. These include diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.

NIDDK plans to host a pre-receipt informational webinar for researchers interested in applying for RFA DK-20-021. It will take place on Monday, November 9, 2020 at 3:00pm ET. Please register by writing to michael.mensah@nih.gov with your name, affiliation and email address.

Scientific/Research Contact(s)

Maren R. Laughlin, Ph.D.
Division of Diabetes, Endocrinology and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Email: Maren.Laughlin@nih.gov"

Source and more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-20-021.html